IL-6 FOR THERAPY OF CHEMOTHERAPY-INDUCED NEUROPATHY
作者： Vitte Pierre-Alain , Dreano Michel
DOI:
关键词: Interleukin 6 、 Low dose 、 Chemotherapy induced 、 Oncology 、 Medicine 、 Internal medicine
摘要: The present invention relates to the use of IL-6 in compositions and methods for therapy or prevention chemotherapy-induced neuropathy (CIPN). More specifically, a low dose treatment and/or CIPN.
lens.org 参考文章(26)
Andrea Margaret Douglas, Colin Glenn Begley, Cytokines and their use in treatment and/or prophylaxis of breast cancer ,(1996)
Gray Shaw, Site-specific homogeneous modification of polypeptides ,(1987)
Donna Rennick, Timothy Mosmann, Frank Lee, Craig Smith, Takashi Yokota, Ken-Ichi Arai, Mammalian interleukin-4 ,(1986)
Leo S. Lin, Shi-Da Yu Lu, David F. Mark, Human recombinant cysteine depleted interferon-β muteins ,(1984)
Daniel H. Doherty, George N. Cox, Immunoglobulin fusion proteins ,(2000)
Robert J. Kreitman, Raj K. Puri, Ira Pastan, Circularly permuted ligands and circularly permuted chimeric molecules ,(1995)
Leo S. Lin, Shi-Da Yu Lu, David F. Mark, Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β ,(1985)
Judith Chebath, Michel Revel, Tsvee Lapidot, Orit Kollet, Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof ,(1998)
Pierre-Alain Vitte, Michel Dreano, USE OF gp130 ACTIVATORS IN DIABETIC NEUROPATHY ,(2002)
David F. Mark, Danutee Nitecti, Kirston E. Koths, Robert F. Halenbeck, Oxidation-resistant muteins of Il-2 and other protein ,(1988)